These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10520809)

  • 1. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.
    Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
    J Am Coll Cardiol; 1999 Oct; 34(4):1176-83. PubMed ID: 10520809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis.
    Aucella F; Margaglione M; Vigilante M; Gatta G; Grandone E; Forcella M; Ktena M; De Min A; Salatino G; Procaccini DA; Stallone C
    Nephrol Dial Transplant; 2003 Jun; 18(6):1142-6. PubMed ID: 12748347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
    Wong TY; Poon P; Szeto CC; Chan JC; Li PK
    Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
    Loew M; Hoffmann MM; Hahmann H; Maerz W; Brenner H; Rothenbacher D
    Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):449-56. PubMed ID: 16926677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
    Kurzawińska G; Barlik M; Drews K; Różycka A; Seremak-Mrozikiewicz A; Ożarowski M; Klejewski A; Czerny B; Wolski H
    Ginekol Pol; 2016; 87(4):271-6. PubMed ID: 27321098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.
    AlBacha Jd; Khoury M; Mouawad C; Haddad K; Hamoui S; Azar A; Fajloun Z; Makdissy N
    PLoS One; 2015; 10(5):e0127266. PubMed ID: 25973747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
    Sakhteh M; Poopak B; Amirizadeh N; Shamshiri A; Bagheri A; Faranoush M
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
    Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.
    Roest M; van der Schouw YT; Banga JD; Tempelman MJ; de Groot PG; Sixma JJ; Grobbee DE
    Circulation; 2000 Jan 4-11; 101(1):67-70. PubMed ID: 10618306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J; Jelicic M; Stojkovic O
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.
    Kim JJ; Choi YM; Lee SK; Yang KM; Paik EC; Jeong HJ; Jun JK; Han AR; Hong MA
    Am J Reprod Immunol; 2014 Dec; 72(6):571-6. PubMed ID: 25078885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of ACE I/D, AT1R A1166C, PAI-I 4G/5G and GPIIIa a1/a2 polymorphisms in myocardial infarction.
    Martínez-Quintana E; Chirino R; Nieto-Lago V; Pérez-Jiménez P; López-Ríos L; Rodríguez-González F
    Cardiol J; 2014; 21(3):229-37. PubMed ID: 23990179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages?
    Goodman C; Hur J; Goodman CS; Jeyendran RS; Coulam C
    Am J Reprod Immunol; 2009 Dec; 62(6):365-70. PubMed ID: 19821806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.